slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Content PowerPoint Presentation
Download Presentation
Content

Loading in 2 Seconds...

play fullscreen
1 / 15

Content - PowerPoint PPT Presentation


  • 95 Views
  • Uploaded on

Current environment for clinical trial conduct in Russia Contract management Mikhail A. Putilovskiy MD, PhD Clinical Operations Manager. Content. Opportunities and threats for CT conduct in Russia Regulatory, legal and accounting peculiarities of clinical trial contracting

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Content' - galya


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Current environment for clinical trial conduct in RussiaContract managementMikhail A. Putilovskiy MD, PhDClinical Operations Manager

content
Content
  • Opportunities and threats for CT conduct in Russia
  • Regulatory, legal and accounting peculiarities of clinical trial contracting
  • Investigators & Institution segmentation
environment opportunities 1
Environment: Opportunities (1)
  • Huge territory and population (141,9 million people)
  • Political stability
  • Centralized HC system
  • Established regulatory review process
  • Local GCP aligned with ICH GCP
  • Possibility of running placebo-controlled trials
  • FDA accepts data from CT conducted in RU only for product registration
environment opportunities 2
Environment: Opportunities (2)
  • High access to various patient population
  • High enrolment speed
  • High quality of data
  • Still considered as a mid/low-cost country with regards to investigator grants
environment threats and challenges
Environment: Threats and challenges
  • Growing cost of experienced staff on the market
  • Decrease in number of people with medical background coming to pharma industry
  • Growing competition in CT sector
content1
Content
  • Opportunities and threats for CT conduct in Russia
  • Regulatory, legal and accounting peculiarities of clinical trial contracting
  • Investigators & Institution segmentation
laws and regulations influencing ct conduct and contracting in russia
Laws and Regulations influencing CT conduct and contracting in Russia
  • Federal Law “On Medicine” №86-ФЗ, of 22.06.1998 with amendments
  • National Standard of the Russian Federation GOST P 52379-2005 “Good Clinical Practice”
  • Order of Ministry of Health of Russian Federation №266 of 19.06.2003 “Procedures for Clinical Practice in Russian Federation”
regulatory and legal peculiarities contradictions in legislation
Direct payments to investigators are allowed:

Federal Law “On Medicines” (based on amendments from 2004)

National Standard (GOST) - GCP

Direct payments to investigators are prohibited:

Order of Ministry of Health – “Procedures for Clinical Practice in Russian Federation”

Regulatory and legal peculiarities: contradictions in legislation?
regulatory and legal peculiarities contradictions in legislation1
Direct payments to investigators are allowed:

Clarification letter from AIPM

Clarification letters from Ministry of Health and Federal Service (2004, 2005, 2009)

Clarification letter from multinational legal firm (2009)

Direct payments to investigators are prohibited:

Clarification letters from 2 multinational legal firms (2004, 2005)

Regulatory and legal peculiarities: contradictions in legislation?
regulatory and legal peculiarities
Regulatory and legal peculiarities
  • Final decision regarding way of contracting and payment in Russia is made internally by legal function of each pharmaceutical company and CRO
content2
Content
  • Opportunities and threats for CT conduct in Russia
  • Regulatory, legal and accounting peculiarities of clinical trial contracting
  • Investigators & Institution segmentation
institution segmentation federal and regional levels
Federal level

Federal State Institutions reporting to the Ministry of Health and Social Development:58 Research Institutes, Educational Institutes, specialized hospitals and clinics

Federal State Institutions reporting to the Federal Medico-biological Agency:124 Research Institutes and specialized supporting agencies

Scientific Institutions reporting to the Russian Academy of Medical Sciences:13 Research Institutes

Regional level

Hospitals and clinics under the umbrella of regional healthcare system

Institution segmentation: Federal and Regional levels
peculiarities of federal level sites
The majority of Institutions are located in Moscow and St. Petersburg and are lead by key OPLs

Huge experience in clinical research

Established Ethical review process

Established logistics for CT conduct

Decreasing enrolment speed and access to the patients

Significant amount of ongoing trials

Decreasing level of interest from the investigators

Significant amount of time required for Contract negotiations with administrative departments (legal, planning, accounting)

Peculiarities of Federal level sites
peculiarities of regional level sites
The majority of sites are located outside of Moscow and St. Petersburg

Less experience in clinical research, logistics for CT conduct isn’t always well established

High enrolment speed and access to the patients

High level of interest from the investigators

Less complicated process of Contracts review

Peculiarities of Regional level sites
key takeaways
Key takeaways
  • There are still great opportunities for CT conduct in Russia
  • Final decision regarding way of contracting and payment in Russia is made internally by each pharmaceutical company and CRO
  • Careful site selection with appropriate balance between Federal and Regional sites is a key to success with future enrolment